These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29088806)

  • 1. High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients.
    Song Q; Liu Y; Jiang D; Wang H; Huang J; Xu Y; Sujie A; Zeng H; Xu C; Hou Y
    Oncotarget; 2017 Sep; 8(43):74539-74553. PubMed ID: 29088806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of fibroblast growth factor receptor 1 gene amplification with poor survival in patients with esophageal squamous cell carcinoma.
    Wang D; Du L; Wang Z; Liu X; Qin Y; Wang Q; Yang Z; Yao Z; Shi M; Shang B; Jia Y; Chen H; Qiao L; Wang X; Xiao Z; Liu Z
    Oncotarget; 2017 Oct; 8(51):88857-88869. PubMed ID: 29179482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
    Kim HR; Kim DJ; Kang DR; Lee JG; Lim SM; Lee CY; Rha SY; Bae MK; Lee YJ; Kim SH; Ha SJ; Soo RA; Chung KY; Kim JH; Lee JH; Shim HS; Cho BC
    J Clin Oncol; 2013 Feb; 31(6):731-7. PubMed ID: 23182986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma.
    Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Jung DH; Shin SK; Lee SK; Lee YC; Kim HR; Moon YW; Kim JH; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC
    Oncotarget; 2015 Feb; 6(4):2562-72. PubMed ID: 25537505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma.
    Huang J; Song Q; Wang H; Wang H; Xu C; Wang X; Jiang Z; Wang Y; Xu Y; Su J; Zeng H; Tan L; Zhu H; Jiang D; Hou Y
    Hum Pathol; 2018 Oct; 80():210-218. PubMed ID: 29936056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and clinicopathological significance of
    Wang Y; Wu Y; Li J; Lai Y; Zhou K; Che G
    Ann Transl Med; 2019 Nov; 7(22):669. PubMed ID: 31930070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of CDK6 amplification in esophageal squamous cell carcinoma.
    Liu K; Lu H; Jiang D; Guan Y; Xu H; Sun Q; Jiang Q; Zheng J; Chen H; Zhang F; Luo R; Huang Y; Xu J; Hou Y
    Cancer Treat Res Commun; 2023; 35():100698. PubMed ID: 37023643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer.
    Flockerzi FA; Roggia C; Langer F; Holleczek B; Bohle RM
    Virchows Arch; 2018 May; 472(5):759-769. PubMed ID: 29270870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor.
    Zhou W; Du X; Song F; Zheng H; Chen K; Zhang W; Yang J
    Oncotarget; 2016 Apr; 7(16):22234-44. PubMed ID: 26993773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed cell death-ligand 1 (PD-L1) expression and fibroblast growth factor receptor 1 (FGFR1) amplification in stage III/IV lung squamous cell carcinoma (SQC).
    Guo Q; Sun Y; Yu S; Bai H; Zhao J; Zhuo M; Wang J
    Thorac Cancer; 2017 Mar; 8(2):73-79. PubMed ID: 28008744
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Wang X; Ge X; Wang H; Huang J; Song Q; Xu C; Jiang Z; Su J; Wang H; Tan L; Jiang D; Hou Y
    Ann Transl Med; 2021 Feb; 9(4):321. PubMed ID: 33708948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse double minute 2 amplification in oesophageal squamous cell carcinoma is associated with better outcome.
    Jiang D; Chen L; Huang J; Wang H; Song Q; Shi P; Wang H; Hou Y
    Histopathology; 2020 Dec; 77(6):963-973. PubMed ID: 32652667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung.
    Usul Afsar C; Sahin B; Gunaldi M; Kılıc Bagir E; Gumurdulu D; Burgut R; Erkisi M; Kara IO; Paydas S; Karaca F; Ercolak V
    Int J Clin Exp Pathol; 2015; 8(9):9760-71. PubMed ID: 26617686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma.
    von Loga K; Kohlhaussen J; Burkhardt L; Simon R; Steurer S; Burdak-Rothkamm S; Jacobsen F; Sauter G; Krech T
    PLoS One; 2015; 10(11):e0141867. PubMed ID: 26555375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pretreatment plasma D-dimer levels and its perioperative change on prognosis in operable esophageal squamous cell carcinoma.
    Li J; Zheng Z; Fang M
    Oncotarget; 2017 Oct; 8(45):79537-79545. PubMed ID: 29108333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative Radiotherapy Improves Survival in Stage pT2N0M0 Esophageal Squamous Cell Carcinoma with High Risk of Poor Prognosis.
    Wang S; Wang Z; Yang Z; Liu Y; Liu X; Shang B; Jiang WP
    Ann Surg Oncol; 2016 Jan; 23(1):265-72. PubMed ID: 26014154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients.
    Zhang F; Chen Z; Wang P; Hu X; Gao Y; He J
    Tumour Biol; 2016 Jul; 37(7):9323-31. PubMed ID: 26779631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
    Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
    Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.
    Park JS; Lee JS; Kim EY; Jung JY; Kim SK; Chang J; Kim DJ; Lee CY; Jung I; Kim JH; Kim HR; Moon YW; Kim HS; Cho BC; Shim HS
    Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC).
    Dworakowska D; Jassem E; Jassem J; Peters B; Dziadziuszko R; Zylicz M; Jakóbkiewicz-Banecka J; Kobierska-Gulida G; Szymanowska A; Skokowski J; Roessner A; Schneider-Stock R
    Lung Cancer; 2004 Mar; 43(3):285-95. PubMed ID: 15165086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.